Abstract
Purified streptococcal M protein vaccines often produce non-type-specific immunotoxic reactions in the skin or the blood of humans. In an attempt to free the type-specific M antigen (TSM) of such non-type-specific (NTSM) immunotoxic properties, purified M protein preparations were subjected to brief periods (5 to 10 min) of enzymatic digestion in dilute solutions of pepsin (20 μg/ml) at pH 5.0. Such peptic digestion abolished the ability of M protein to aggregate platelets in human platelet-rich plasma and to precipitate plasma fibrinogen. It greatly reduced (up to 16-fold) the capacity of M protein to react with the NTSM complement-fixing antibody that is normally present in human serum. In contrast, it had no effect upon the reactivity of the type-specific M antigen; the pepsin-treated M protein retained its ability to inhibit type-specific streptococcal opsonization by homologous M antibody, and, moreover, retained its ability to elicit type-specific opsonic antibody responses in rabbits.
Full text
PDF![244](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263b/414793/68b088f0255f/iai00242-0046.png)
![245](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263b/414793/f4dd7cf60e8c/iai00242-0047.png)
![246](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263b/414793/c43bb3237e46/iai00242-0048.png)
![247](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263b/414793/52e10588c403/iai00242-0049.png)
![248](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263b/414793/04f93f3ded32/iai00242-0050.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BLEIWEIS A. S., KARAKAWA W. W., KRAUSE R. M. IMPROVED TECHNIQUE FOR THE PREPARATION OF STREPTOCOCCAL CELL WALLS. J Bacteriol. 1964 Oct;88:1198–1200. doi: 10.1128/jb.88.4.1198-1200.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BORN G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. doi: 10.1038/194927b0. [DOI] [PubMed] [Google Scholar]
- Beachey E. H., Alberti H., Stollerman G. H. Delayed hypersensitivity to purified streptococcal m protein in guinea pigs and in man. J Immunol. 1969 Jan;102(1):42–52. [PubMed] [Google Scholar]
- Beachey E. H., Cunningham M. Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins. Infect Immun. 1973 Jul;8(1):19–24. doi: 10.1128/iai.8.1.19-24.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beachey E. H., Stollerman G. H. Mediation of cytotoxic effects of streptococcal M protein by nontype-specific antibody in human sera. J Clin Invest. 1973 Oct;52(10):2563–2570. doi: 10.1172/JCI107448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beachey E. H., Stollerman G. H. The common antigen(s) of streptococcal M protein vaccines causing hyperimmune reactions in man. Trans Assoc Am Physicians. 1972;85:212–221. [PubMed] [Google Scholar]
- Beachey E. H., Stollerman G. H. Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood. J Exp Med. 1971 Aug 1;134(2):351–365. doi: 10.1084/jem.134.2.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Becker C. G. Enhancing effect of type specific antistreptococcal antibodies on emergence of streptococci rich in M-protein. Proc Soc Exp Biol Med. 1967 Jan;124(1):331–335. doi: 10.3181/00379727-124-31736. [DOI] [PubMed] [Google Scholar]
- DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
- Fox E. N., Wittner M. K., Dorfman A. Antigenicity of the M proteins of group A hemolytic streptococci. 3. Antibody responses and cutaneous hypersensitivity in humans. J Exp Med. 1966 Dec 1;124(6):1135–1151. doi: 10.1084/jem.124.6.1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fox E. N., Wittner M. K. New observations on the structure and antigenicity of the M proteins of the group A streptococcus. Immunochemistry. 1969 Jan;6(1):11–24. doi: 10.1016/0019-2791(69)90174-8. [DOI] [PubMed] [Google Scholar]
- KANTOR F. S., COLE R. M. A fibrinogen precipitating factor (FPF) of group A streptococci. Proc Soc Exp Biol Med. 1959 Oct;102:146–150. doi: 10.3181/00379727-102-25172. [DOI] [PubMed] [Google Scholar]
- Katzman R. L., Kang A. H., Beachey E. H. Collagen-induced platelet aggregation: involement of an active glycopeptide fragment (alpha1-CB5). Science. 1973 Aug 17;181(4100):670–672. doi: 10.1126/science.181.4100.670. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Stollerman G. H. Prospects for a vaccine against group A streptococci: the problem of the immunology of M proteins. Arthritis Rheum. 1967 Jun;10(3):245–255. doi: 10.1002/art.1780100311. [DOI] [PubMed] [Google Scholar]
- Widdowson J. P., Maxted W. R., Pinney A. M. An M-associated protein antigen (MAP) of group A streptococci. J Hyg (Lond) 1971 Dec;69(4):553–564. doi: 10.1017/s0022172400021823. [DOI] [PMC free article] [PubMed] [Google Scholar]